antidepressants

• antidepressants somehow interact with the two neurotransmitters, norepinephrine and serotonin, that regulate mood, arousal, attention, sensory processing, and appetite.
• a life-threatening side effect, hypertensive crisis, may occur if the client ingests foods containing tyramine while taking MAOIs.
• because of the risk of potentially fatal drug interactions, MAOIs cannot be given in combination with other MAOIs, (T) tricyclic antidepressants, (M) meperidine (Demerol), CNS (D) depressants, many anti (H) hypertensives, or (G) general anesthetics.
• because of the risk of potentially fatal drug interactions, MAOIs cannot be given in combination with other MAOIs, (T) tricyclic antidepressants, (M) meperidine (Demerol), CNS (D) depressants, many anti (H) hypertensives, or (G) general anesthetics.
• because of the risk of potentially fatal drug interactions, MAOIs cannot be given in combination with other MAOIs, (T) tricyclic antidepressants, (M) meperidine (Demerol), CNS (D) depressants, many anti (H) hypertensives, or (G) general anesthetics.
• because of the risk of potentially fatal drug interactions, MAOIs cannot be given in combination with other MAOIs, (T) tricyclic antidepressants, (M) meperidine (Demerol), CNS (D) depressants, many anti (H) hypertensives, or (G) general anesthetics.
• because of the risk of potentially fatal drug interactions, MAOIs cannot be given in combination with other MAOIs, (T) tricyclic antidepressants, (M) meperidine (Demerol), CNS (D) depressants, many anti (H) hypertensives, or (G) general anesthetics.
• (S) SSRIs, (V) venlafaxine, (N) nefazodone, and (B) bupropion are often better choices for those who are potentially suicidal or highly impulsive because they carry no risk of lethal overdose in contrast to the cyclic compounds and the MAOIs.
• (S) SSRIs, (V) venlafaxine, (N) nefazodone, and (B) bupropion are often better choices for those who are potentially suicidal or highly impulsive because they carry no risk of lethal overdose in contrast to the cyclic compounds and the MAOIs.
• (S) SSRIs, (V) venlafaxine, (N) nefazodone, and (B) bupropion are often better choices for those who are potentially suicidal or highly impulsive because they carry no risk of lethal overdose in contrast to the cyclic compounds and the MAOIs.
• (S) SSRIs, (V) venlafaxine, (N) nefazodone, and (B) bupropion are often better choices for those who are potentially suicidal or highly impulsive because they carry no risk of lethal overdose in contrast to the cyclic compounds and the MAOIs.
• SSRIs are effective only for mild and moderate depression.
• the SSRIs block the reuptake of serotonin.
• the cyclic antidepressants and venlafaxine block the reuptake of norepinephrine primarily and block serotonin to some degree.
• the MAOIs interfere with enzyme MAO metabolism.
• the cyclic compounds may take 4 to 6 weeks to be effective
• MAOIs need 2 to 4 weeks for effectiveness
• SSRIs may be effective in 2 to 3 weeks
• SSRI

  • enhanced serotonin transmission can lead to several common side effects such as (a) anxiety, (a) agitation, (a) akathisia, (n) nausea, (i) insomnia, sexual (d) dysfunction , weight (g) gain
• SSRI

  • enhanced serotonin transmission can lead to several common side effects such as (a) anxiety, (a) agitation, (a) akathisia, (n) nausea, (i) insomnia, sexual (d) dysfunction , weight (g) gain
• SSRI

  • enhanced serotonin transmission can lead to several common side effects such as (a) anxiety, (a) agitation, (a) akathisia, (n) nausea, (i) insomnia, sexual (d) dysfunction , weight (g) gain
• SSRI

  • enhanced serotonin transmission can lead to several common side effects such as (a) anxiety, (a) agitation, (a) akathisia, (n) nausea, (i) insomnia, sexual (d) dysfunction , weight (g) gain
• SSRI

  • enhanced serotonin transmission can lead to several common side effects such as (a) anxiety, (a) agitation, (a) akathisia, (n) nausea, (i) insomnia, sexual (d) dysfunction , weight (g) gain
• SSRI

  • enhanced serotonin transmission can lead to several common side effects such as (a) anxiety, (a) agitation, (a) akathisia, (n) nausea, (i) insomnia, sexual (d) dysfunction , weight (g) gain
• SSRI

  • less common side effects include (s) sedation (particularly with paroxetine [Paxil]), (s) sweating, (d) diarrhea, hand (t) tremor, and (h) headaches.
• SSRI

  • less common side effects include (s) sedation (particularly with paroxetine [Paxil]), (s) sweating, (d) diarrhea, hand (t) tremor, and (h) headaches.
• SSRI

  • less common side effects include (s) sedation (particularly with paroxetine [Paxil]), (s) sweating, (d) diarrhea, hand (t) tremor, and (h) headaches.
• SSRI

  • less common side effects include (s) sedation (particularly with paroxetine [Paxil]), (s) sweating, (d) diarrhea, hand (t) tremor, and (h) headaches.
• SSRI

  • less common side effects include (s) sedation (particularly with paroxetine [Paxil]), (s) sweating, (d) diarrhea, hand (t) tremor, and (h) headaches.
• akathisia is usually treated with a beta-blocker or a benzodiazepine.
• the cyclic antidepressants

  • block cholinergic receptors, resulting in anticholinergic effects such as (d) dry mouth, (c) constipation, urinary (h, R)hesitancy or retention, (d) dry nasal passages, and (b) blurred near vision.
• the cyclic antidepressants

  • block cholinergic receptors, resulting in anticholinergic effects such as (d) dry mouth, (c) constipation, urinary (h, R)hesitancy or retention, (d) dry nasal passages, and (b) blurred near vision.
• the cyclic antidepressants

  • block cholinergic receptors, resulting in anticholinergic effects such as (d) dry mouth, (c) constipation, urinary (h, R)hesitancy or retention, (d) dry nasal passages, and (b) blurred near vision.
• the cyclic antidepressants

  • block cholinergic receptors, resulting in anticholinergic effects such as (d) dry mouth, (c) constipation, urinary (h, R)hesitancy or retention, (d) dry nasal passages, and (b) blurred near vision.
• the cyclic antidepressants

  • block cholinergic receptors, resulting in anticholinergic effects such as (d) dry mouth, (c) constipation, urinary (h, R)hesitancy or retention, (d) dry nasal passages, and (b) blurred near vision.
• cyclic antidpressants

  • more severe anticholinergic effects such as (A) agitation, (D) delirium, and (I) ileus may occur, particularly in older adults.
• cyclic antidpressants

  • more severe anticholinergic effects such as (A) agitation, (D) delirium, and (I) ileus may occur, particularly in older adults.
• cyclic antidpressants

  • more severe anticholinergic effects such as (A) agitation, (D) delirium, and (I) ileus may occur, particularly in older adults.
• cyclic antidepressants

  • other common side effects include (o, h) orthostatic hypotension, (S) sedation, weight (G) gain, and (T) tachycardia.
• cyclic antidepressants

  • other common side effects include (o, h) orthostatic hypotension, (S) sedation, weight (G) gain, and (T) tachycardia.